[Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
Lucidarme
Damien
D
Service d'Hépato-Gastro-Entérologie, Hôpital Saint-Philibert, 115, rue du Grand-But, 59160 Lomme.
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D006556:Heroin Dependence / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D015995:Prevalence; D011330:Prisons; D011379:Prognosis; D011446:Prospective Studies; D012008:Recurrence; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D013997:Time Factors
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons